Guillain-Barré Syndrome After COVID-19 mRNA Vaccination in a Liver Transplantation Recipient With Favorable Treatment Response.

Hughes, Dempsey L; Brunn, Jenna A; Jacobs, Jansen; Todd, Peter K; Askari, Fredrick K; Fontana, Robert J

Hughes, Dempsey L; Brunn, Jenna A; Jacobs, Jansen; Todd, Peter K; Askari, Fredrick K; Fontana, Robert J.

Affiliation

Hughes DL; Division of Gastroenterology and Hepatology University of Michigan Ann Arbor MI Department of Neurology University of Michigan Ann Arbor MI Department of Internal Medicine University of Michigan Ann Arbor MI.

Liver Transpl ; 28(1): 134-137, 2022 01.

Article in En | MEDLINE | ID: mdl-34431208

Subject(s)

COVID-19; Guillain-Barre Syndrome; Liver Transplantation; Guillain-Barre Syndrome/diagnosis; Guillain-Barre Syndrome/etiology; Humans; Liver Transplantation/adverse effects; RNA, Messenger; SARS-CoV-2; Vaccination/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Liver Transplantation / Guillain-Barre Syndrome / COVID-19 Type of study: Diagnostic_studies / Etiology_studies Limits: Humans Language: En Journal: Liver Transpl Journal subject: GASTROENTEROLOGIA / TRANSPLANTE Year: 2022 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google